The incidence of immunodeficiency and autoimmune diseases continues to increase annually, especially in countries with an underdeveloped pharmaceutical market, making insect therapy a widely used treatment. The goal of this research is to investigate the potential of using Ulomoides dermestoides beetles as a raw material for the development of an immunomodulatory agent. A review of the available literature revealed the therapeutic potential of U. dermestoides beetles in the treatment of various
No takes yet. Share an insight, caveat, or question.
Beibalaeva et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: